EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19‐9 in Predicting Colorectal Cancer Liver Metastasis

Hong-Bo Ji, Bo Qian, Jian-Jun Hu, Wei Qi, Zi-Gang Che iD

Journal of Clinical Ultrasound · 2025

DOI: 10.1002/jcu.23917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Ultrasound, 2025. Verfasst von Hong-Bo Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: CA-19-9 Antigen, Colorectal Neoplasms, Carcinoembryonic Antigen, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanjing Medical Science and Technology Development Project (YKK16262), and 13th Five-Year Nanjing Health Youth Talent Training Project (QRX17207).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) combined with serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA19‐9) levels to evaluate the efficacy of colorectal cancer liver metastasis (CRCLM) treatment is still rare.

Purpose

To investigate the predictive value of DCE‐MRI combined with serum CEA and CA 19‐9 concerning the efficacy of comprehensive treatment for CRCLM. Materials and Methods A total of 120 patients with CRC were retrospectively recruited using convenience sampling between May 2019 and March 2024. After treatment, they were divided into two groups according to the treatment efficacy: responders (86 cases) and non‐responders (34 cases), and their clinical data were collected for comparison.

Results

Before treatment, there were statistically significant differences between the groups in terms of the proportion of positive CEA ( χ 2 = 17.364, p < 0.001), the proportion of positive CA 19‐9 ( χ 2 = 23.639, p < 0.001), the rate constant of a contrast agent from the vascular to the interstitial compartment ( K trans ) ( χ 2 = 2.341, p = 0.023), and the rate constant between the extravascular extracellular space (EES) ( K ep ) ( χ 2 = 2.556, p = 0.011). The values of K trans , K ep , CEA, and CA 19‐9 reflected a certain degree of predictive value for the efficacy of comprehensive treatment in patients with CRCLM ( p < 0.05). The combination of the four measurements is better than any single value, with an area under the curve of 0.898 (95% CI: 0.833, 0.922).

Conclusion

Dynamic contrast‐enhanced magnetic resonance imaging, CEA, and CA 19‐9 have predictive value for the early efficacy of comprehensive treatment for CRCLM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CA-19-9 AntigenColorectal NeoplasmsCarcinoembryonic AntigenLiver NeoplasmsMagnetic Resonance ImagingContrast MediaImage EnhancementHumansFemaleMaleMiddle AgedRetrospective StudiesAgedPredictive Value of TestsAdultBiomarkers, TumorLiver

Stichwörter der Autor:innen

carbohydrate antigen 19‐9carcinoembryonic antigencolorectal cancer liver metastasesdynamic contrast‐enhanced magnetic resonance imaging

Substanzen

CA-19-9 AntigenCarcinoembryonic AntigenContrast MediaBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Imaging, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Department of Hemato-Oncology, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Department of Medical Laboratory, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.

ORCID-Profile: Zi-Gang Che

Förderung

  • Nanjing Medical Science and Technology Development Project (YKK16262), and 13th Five-Year Nanjing Health Youth Talent Training Project (QRX17207)

Zitieren

APA

Ji, H. B., Qian, B., Hu, J. J., Qi, W., & Che, Z. G. (2025). Use of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19‐9 in Predicting Colorectal Cancer Liver Metastasis. Journal of Clinical Ultrasound. https://doi.org/10.1002/jcu.23917

Vancouver

Ji HB, Qian B, Hu JJ, Qi W, Che ZG. Use of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19‐9 in Predicting Colorectal Cancer Liver Metastasis. Journal of Clinical Ultrasound. 2025. doi:10.1002/jcu.23917

BibTeX
@article{Ji2025,
  author = {Ji, Hong-Bo and Qian, Bo and Hu, Jian-Jun and Qi, Wei and Che, Zi-Gang},
  title = {Use of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19‐9 in Predicting Colorectal Cancer Liver Metastasis},
  journal = {Journal of Clinical Ultrasound},
  year = {2025},
  doi = {10.1002/jcu.23917}
}
Kostenlos starten →